Equities researchers at Leerink Partnrs reduced their FY2026 earnings per share estimates for shares of Madrigal Pharmaceuticals in a note issued to investors on Wednesday, February 5th. Leerink ...

The Mets even supplemented their infield mix by signing Nick Madrigal, who was non-tendered by the Chicago Cubs, late last ...

The Mets will have an additional experienced infielder to consider for a utility role this spring. Nick Madrigal, a player ...

The New York Mets signed infielder Nick Madrigal to a one-year contract Friday. Madrigal hit .221 with 10 RBIs in 51 games ...

The Mets struck a deal for another potential bench bat on Friday, signing infielder Nick Madrigal to a one-year pact. It's a ...

Could this spell the end of Candelita in Queens? OMG. The New York Mets have signed versatile infielder Nick Madrigal to a ...

Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the thirteen analysts that are presently covering the stock, ...

The Mets have a one-year agreement with infielder Nick Madrigal, the club announced. It’s reportedly a split deal that pays ...

Madrigal Pharmaceuticals (MDGL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yasmeen ...

The New York Mets agreed to a one-year, $1.35-million deal with infielder Nick Madrigal on Friday, according to Joel Sherman ...

The Mets added some depth to their infield Friday, signing former Cub Nick Madrigal to a one-year, split contract, a source ...

Looking to add to their infield depth, the New York Mets agreed to a one-year deal with veteran Nick Madrigal on Friday, league sources confirmed. The New York Post first reported the agreement.